Expression of the serine protease Desc1 correlates directly with normal keratinocyte differentiation and inversely with head and neck squamous cell carcinoma progression

被引:20
|
作者
Sedghizadeh, PP
Mallery, SR
Thompson, SJ
Kresty, L
Beck, FM
Parkinson, EK
Biancamano, J
Lang, JC
机构
[1] Ohio State Univ, Coll Dent, Dept Oral & maxillofacial Surg Oral & Maxillofaci, Columbus, OH 43218 USA
[2] Ohio State Univ, Arthur G James Canc Hosp, Ctr Comprehens Canc, Columbus, OH 43210 USA
[3] Richard J Solove Res Inst, Columbus, OH USA
[4] Ohio State Univ, Coll Med, Dept Internal Med, Div Hematol & Oncol, Columbus, OH 43210 USA
[5] Ohio State Univ, Coll Dent, Dept Oral Biol, Columbus, OH 43210 USA
[6] Ohio State Univ, Coll Med, Dept Otolaryngol, Columbus, OH 43210 USA
[7] CR UK Beatson Labs, Glasgow G61 1BD, Lanark, Scotland
关键词
DESC1; head and neck squamous cell carcinoma (HNSCC); serine protease;
D O I
10.1002/hed.20346
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. As part of ongoing studies aimed at identifying the molecular events involved in head and neck squamous cell carcinoma progression, we recently isolated a novel serine protease, DESC1. This study was conducted to further characterize DESC1. Methods. Specimens of normal, dysplastic, and carcinomatous oropharyngeal mucosa (n = 31) were evaluated for DESC1 immunoreactivity using standard streptavidin-biotin immunoperoxidase techniques. Between-lesion stain intensity values were analyzed using multiple Wilcoxon tests. DESC1 expression was also evaluated in cultured human keratinocytes after induction of differentiation by calcium challenge, with subsequent real-time reverse transcriptase-polymerase chain reaction quantification. Results. DESC1 immunoreactivity decreased as lesions approached a malignant phenotype. Post hoc testing comparing the different lesion types and DESC1 staining values showed significance between 'normal' and 'carcinoma' (p =.0017) groups. Induction of normal keratinocyte differentiation by calcium challenge was accompanied by an increase in DESC1 expression (p =.002). Conclusions. These results suggest downregulation of DESC1 during squamous cell carcinoma progression and upregulation during normal epithelial differentiation. (c) 2005 Wiley Periodicals, Inc.
引用
收藏
页码:432 / 440
页数:9
相关论文
共 50 条
  • [41] Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines
    Patel, AM
    Incognito, LS
    Schechter, GL
    Wasilenko, WJ
    Somers, KD
    [J]. ONCOGENE, 1996, 12 (01) : 31 - 35
  • [42] YTHDC1 Promotes Stemness Maintenance and Malignant Progression in Head and Neck Squamous Cell Carcinoma
    Weng, Junquan
    Fan, Haidong
    Liu, Huijuan
    Tang, Su
    Zheng, Yuyan
    [J]. STEM CELLS INTERNATIONAL, 2022, 2022
  • [43] Identity of MMP1 and its effects on tumor progression in head and neck squamous cell carcinoma
    Zhang, Gehou
    Li, Tieqi
    Tan, Guolin
    Song, Yexun
    Liu, Qian
    Wang, Kai
    Ai, Jingang
    Zhou, Zheng
    Li, Wei
    [J]. CANCER MEDICINE, 2022, 11 (12): : 2516 - 2530
  • [44] Immunotherapeutic implications of mucin 1/16 expression in head and neck squamous cell carcinoma (HNSCC)
    Rampias, T.
    Gavrielatou, N.
    Panagiota, O.
    Kotsantis, I.
    Anastasiou, M.
    Pantazopoulos, A.
    Chatzidakis, I.
    Kavourakis, G.
    Kontos, C.
    Golfinopoulos, S.
    Polyzos, A.
    Giotakis, E.
    Scorilas, A.
    Foukas, P.
    Psyrri, A.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S679 - S680
  • [45] Lewd expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma (HNSCC)
    Liu, KL
    Mukunyadzi, P
    Hanna, E
    Suen, JY
    Walker, PD
    Sanderson, RD
    Fan, CY
    [J]. LABORATORY INVESTIGATION, 2001, 81 (01) : 151A - 151A
  • [46] Diagnostic and prognostic value of FOXD1 expression in head and neck squamous cell carcinoma
    Qiu, Shijie
    Li, Dan
    Shen, Zhisen
    Li, Qun
    Shen, Yi
    Deng, Hongxia
    Wu, Yidong
    Zhou, Chongchang
    [J]. JOURNAL OF CANCER, 2021, 12 (03): : 693 - 702
  • [47] Prognosis of Midkine and AT1R expression in resectable head and neck squamous cell carcinoma
    Chiu, Tai-Jan
    Chen, Chang-Han
    Chen, Yi-Ju
    Wee, Yinshen
    Wang, Ching-Shuen
    Luo, Sheng-Dean
    [J]. CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [48] The prognostic value of cyclin D1 expression in head and neck squamous cell carcinoma
    Federico M. Gioacchini
    Matteo Alicandri-Ciufelli
    Shaniko Kaleci
    Giuseppe Magliulo
    Livio Presutti
    Massimo Re
    [J]. European Archives of Oto-Rhino-Laryngology, 2016, 273 : 801 - 809
  • [49] PDL1 expression testing in head and neck squamous cell carcinoma: Bridging the gap
    Choudhary, Vaibhav
    [J]. INDIAN JOURNAL OF CANCER, 2022, 59 (04) : 455 - 456
  • [50] The prognostic value of cyclin D1 expression in head and neck squamous cell carcinoma
    Gioacchini, Federico M.
    Alicandri-Ciufelli, Matteo
    Kaleci, Shaniko
    Magliulo, Giuseppe
    Presutti, Livio
    Re, Massimo
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2016, 273 (04) : 801 - 809